Found: 8
Select item for more details and to access through your institution.
Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2-59 Months of Age, Spain.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Infrequent detection of hepatitis E virus RNA in pregnant women with hepatitis E virus antibodies in Spain.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 387, doi. 10.3390/vaccines8030387
- By:
- Publication type:
- Article
Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13‐valent pneumococcal conjugate vaccine era.
- Published in:
- Pediatric Pulmonology, 2019, v. 54, n. 5, p. 517, doi. 10.1002/ppul.24279
- By:
- Publication type:
- Article
Cost-effectiveness of breast cancer screening in Spain.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0228612
- By:
- Publication type:
- Article
Influence of socioeconomic status on community-acquiredpneumonia outcomes in elderly patientsrequiring hospitalization: a multicenterobservational study.
- Published in:
- BMC Public Health, 2010, v. 10, n. 1, p. 421
- By:
- Publication type:
- Article
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183191
- By:
- Publication type:
- Article